The monoclonal B7-H3 antibody that has been radiolabeled with lutetium-177—currently under investigation as part of a multicenter Phase 1/2 clinical trial (NCT04167618) in pediatric patients…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.